RXT:NASDAQRackspace Technology, Inc. Analysis
Data as of 2026-08-19 - not real-time
$3.52
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $3.52, Rackspace Technology, Inc. shows no decisive moving-average alignment, leaving the trend neutral. It has lost 47.9% over the past 30 days. RSI sits at 37.0, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at $3.51 up to resistance at $5.67.
On valuation the read is undervalued — earnings multiple of 25.9 versus a 35.7 sector average, below the peer group. Consensus targets land 35.4% above where the shares trade now.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 165.9%, a beta of 2.68 and a maximum drawdown of 77.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
On valuation the read is undervalued — earnings multiple of 25.9 versus a 35.7 sector average, below the peer group. Consensus targets land 35.4% above where the shares trade now.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 165.9%, a beta of 2.68 and a maximum drawdown of 77.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Top Market Events
RXT Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action...RXT DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Rackspace Technology RXT Investors of Securities Class Action Lawsuit...NASDAQ: RXT: Kessler Topaz Meltzer & Check, LLP Announces The Filing Of A Securities Fraud Class Action Lawsuit Against...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 2.61
- MACD momentum is negative
- 30-day price change of -47.9%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 25.9 versus sector average of 35.7
- Trading above the 200-day average of 2.61
- Analyst targets imply +35.4% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 25.9 versus sector average of 35.7
- Negative profit margin of -5.9%
- Analyst targets imply +35.4% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth0.60%
Profit Margin-5.88%
P/E Ratio25.9
ROA-0.96%
P/B Ratio-0.7
Op. Cash Flow$104.0M
Free Cash Flow$186.6M
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI37.0
Support$3.51
Resistance$5.67
MA 20$4.30
MA 50$5.14
MA 200$2.61
MACDBearish
VolumeIncreasing
Fear & Greed Index93.8
Valuation
Target Price$4.77
Upside/Downside35.42%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.68
Volatility165.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.